Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Country/Region as subject
Language
Affiliation country
Publication year range
1.
J Cancer Res Clin Oncol ; 148(2): 377-386, 2022 Feb.
Article in English | MEDLINE | ID: mdl-34739585

ABSTRACT

PURPOSE: Forkhead Box Protein 3 (FoxP3) is known as a key mediator in the immunosuppressive function of regulatory T-cells (Tregs). The aim of our study was to investigate whether FoxP3-positive Tregs have the potential to act as an independent predictor in progression as well as in regression of cervical intraepithelial neoplasia, especially in patients with intermediate cervical intraepithelial neoplasia (CIN II). METHODS: Nuclear FoxP3 expression was immunohistochemically analysed in 169 patient samples (CIN I, CIN II with regressive course, CIN II with progressive course, CIN III). The median numbers were calculated for each slide and correlated with the histological CIN grade. Statistical analysis was performed by SPSS 26 (Mann-Whitney U test, Spearman's rank correlation). RESULTS: An increased FoxP3 expression in CIN II with progression could be detected in comparison to CIN II with regression (p = 0.003). Total FoxP3 expression (epithelium and dysplasia-connected stroma) was higher in more advanced CIN grades (p < 0.001 for CIN I vs. CIN II; p = 0.227 for CIN II vs. CIN III). A positive correlation could be detected between FoxP3-positive cells in epithelium and total FoxP3 expression (Spearman's Rho: 0,565; p < 0.01). CONCLUSION: Expression of FoxP3 could be a helpful predictive factor to assess the risks of CIN II progression. As a prognosticator for regression and progression in cervical intraepithelial lesions it might thereby help in the decision process regarding surgical treatment vs. watchful waiting strategy to prevent conisation-associated risks for patients in child-bearing age. In addition, the findings support the potential of Tregs as a target for immune therapy in cervical cancer patients.


Subject(s)
Forkhead Transcription Factors/metabolism , T-Lymphocytes, Regulatory/physiology , Uterine Cervical Dysplasia/pathology , Uterine Cervical Neoplasms/pathology , Adolescent , Adult , Biomarkers, Tumor/metabolism , Disease Progression , Female , Germany , Humans , Immunohistochemistry , Middle Aged , Neoplasm Regression, Spontaneous/pathology , Papillomavirus Infections/immunology , Papillomavirus Infections/metabolism , Papillomavirus Infections/pathology , Prognosis , T-Lymphocytes, Regulatory/metabolism , T-Lymphocytes, Regulatory/pathology , Uterine Cervical Neoplasms/diagnosis , Uterine Cervical Neoplasms/immunology , Uterine Cervical Neoplasms/metabolism , Young Adult , Uterine Cervical Dysplasia/diagnosis , Uterine Cervical Dysplasia/immunology , Uterine Cervical Dysplasia/metabolism
2.
J Cancer Res Clin Oncol ; 146(7): 1847-1855, 2020 Jul.
Article in English | MEDLINE | ID: mdl-32157438

ABSTRACT

PURPOSE: Ligand-dependent corepressor (LCoR) and receptor-interacting protein 140 (RIP140/NRIP1) play an important role in the regulation of multiple oncogenic signaling pathways and the development of cancer. LCoR and RIP140 form a nuclear complex in breast cancer cells and are of prognostic value in further prostate and cervical cancer. The purpose of this study was to analyze the regulation of these proteins in the development of cervical intraepithelial neoplasia (CIN I-III). METHODS: Immunohistochemical analysis was obtained to quantify RIP140 and LCoR expression in formalin-fixed paraffin embedded tissue sections of cervical intraepithelial neoplasia samples. Tissue (n = 94) was collected from patients treated in the Department of Gynecology and Obstetrics, Ludwig-Maximilians-University of Munich, Germany, between 2002 and 2014. Correlations of expression levels with clinical outcome were carried out to assess for prognostic relevance in patients with CIN2 progression. Kruskal-Wallis test and Mann-Whitney U test were used for data analysis. RESULTS: Nuclear LCoR overexpression correlates significantly with CIN II progression. Nuclear RIP140 expression significantly increases and nuclear LCoR expression decreases with higher grading of cervical intraepithelial neoplasia. Cytoplasmic RIP140 expression is significantly higher in CIN III than in CIN I or CIN II. CONCLUSION: A decrease of nuclear LCoR expression in line with an increase of dedifferentiation of CIN can be observed. Nuclear LCoR overexpression correlates with CIN II progression indicating a prognostic value of LCoR in cervical intraepithelial neoplasia. Nuclear and cytoplasmic RIP140 expression increases significantly with higher grading of cervical intraepithelial neoplasia underlining its potential role in the development of pre-cancerous lesions. These findings support the relevance of LCoR and RIP140 in the tumorigenesis indicating a possible role of LCoR and RIP140 as targets for novel therapeutic approaches in cervical intraepithelial neoplasia and cervical cancer.


Subject(s)
Cell Dedifferentiation , Nuclear Receptor Interacting Protein 1/metabolism , Repressor Proteins/metabolism , Uterine Cervical Dysplasia/metabolism , Uterine Cervical Dysplasia/pathology , Biomarkers, Tumor , Cell Dedifferentiation/genetics , Disease Progression , Female , Gene Expression Regulation, Neoplastic , Humans , Immunohistochemistry , Neoplasm Grading , Nuclear Receptor Interacting Protein 1/genetics , Repressor Proteins/genetics , Uterine Cervical Dysplasia/genetics
SELECTION OF CITATIONS
SEARCH DETAIL